Compositions and method for treatment and prophylaxis of inflammatory bowel disease

摘要

Methods and compositions for treating inflammatory bowel disease involve the use of targeted antibiotics in combination with probiotic formulations. The probiotics mitigate many of the deleterious side effects associated with antibiotic use and permit the antibiotic to be administered at a higher dose and for a longer duration than would otherwise be possible in the absence of the probiotic. The practice of the invention may reduce or eliminate the use of immunosuppressants in the treatment and management of IBD.

主权项

1. An oral dosage form for the treatment of inflammatory bowel disease due to bacterial infection, said dosage form comprising:
(i) a delayed-release component comprising an amount of antibiotic effective to reduce colonization of pathogenic bacteria in the gastrointestinal tract, said antibiotic comprising a combination of sulfamethoxazole and trimethoprim; and (ii) an immediate-release component comprising a probiotic formulation in an amount effective to restore normal microflora colonies in the gut; wherein said immediate-release component releases said probiotic formulation upon contact with fluid in the stomach; and wherein said delayed-release component releases said antibiotic at a pH of 7 or greater.